202 related articles for article (PubMed ID: 23063027)
1. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.
Farrokhi F; Klindukhova O; Chandra P; Peng L; Smiley D; Newton C; Pasquel F; Fereira ME; Umpierrez G
J Diabetes Sci Technol; 2012 Sep; 6(5):1022-9. PubMed ID: 23063027
[TBL] [Abstract][Full Text] [Related]
2. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.
Smiley D; Umpierrez GE; Hermayer K; Newton C; Jacobs S; Olson DE; Khan A; Rizzo M; Peng L; Reyes D; Cardona S; Fonseca V
J Diabetes Complications; 2013; 27(6):637-41. PubMed ID: 23911535
[TBL] [Abstract][Full Text] [Related]
3. Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE; Smiley D; Hermayer K; Khan A; Olson DE; Newton C; Jacobs S; Rizzo M; Peng L; Reyes D; Pinzon I; Fereira ME; Hunt V; Gore A; Toyoshima MT; Fonseca VA
Diabetes Care; 2013 Aug; 36(8):2169-74. PubMed ID: 23435159
[TBL] [Abstract][Full Text] [Related]
4. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.
Bueno E; Benitez A; Rufinelli JV; Figueredo R; Alsina S; Ojeda A; Samudio S; Cáceres M; Argüello R; Romero F; Echagüe G; Pasquel F; Umpierrez GE
Endocr Pract; 2015 Jul; 21(7):807-13. PubMed ID: 26121460
[TBL] [Abstract][Full Text] [Related]
5. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Umpierrez GE; Smiley D; Jacobs S; Peng L; Temponi A; Mulligan P; Umpierrez D; Newton C; Olson D; Rizzo M
Diabetes Care; 2011 Feb; 34(2):256-61. PubMed ID: 21228246
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
Umpierrez GE; Hor T; Smiley D; Temponi A; Umpierrez D; Ceron M; Munoz C; Newton C; Peng L; Baldwin D
J Clin Endocrinol Metab; 2009 Feb; 94(2):564-9. PubMed ID: 19017758
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
Bellido V; Suarez L; Rodriguez MG; Sanchez C; Dieguez M; Riestra M; Casal F; Delgado E; Menendez E; Umpierrez GE
Diabetes Care; 2015 Dec; 38(12):2211-6. PubMed ID: 26459273
[TBL] [Abstract][Full Text] [Related]
9. COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
Haw JS; Farrokhi F; Smiley D; Peng L; Reyes D; Newton C; Pasquel FJ; Vellanki P; Umpierrez GE
Endocr Pract; 2015 Dec; 21(12):1333-43. PubMed ID: 26307899
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
Fayfman M; Galindo RJ; Rubin DJ; Mize DL; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P; Wang H; Albury BS; Weaver R; Cardona S; Umpierrez GE
Diabetes Care; 2019 Mar; 42(3):450-456. PubMed ID: 30679302
[TBL] [Abstract][Full Text] [Related]
11. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
Christensen MB; Gotfredsen A; Nørgaard K
Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28067472
[TBL] [Abstract][Full Text] [Related]
13. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients.
Franchin A; Maran A; Bruttomesso D; Corradin ML; Rossi F; Zanatta F; Barbato GM; Sicolo N; Manzato E
Aging Clin Exp Res; 2017 Dec; 29(6):1087-1093. PubMed ID: 28238154
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
Mathur SK; Bansal A; Khan ZY
J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
[TBL] [Abstract][Full Text] [Related]
15. Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.
Polonsky WH; Thompson S; Wei W; Riddle MC; Chaudhari S; Jackson J; Bruno AS
Diabetes Obes Metab; 2014 Nov; 16(11):1121-7. PubMed ID: 24919603
[TBL] [Abstract][Full Text] [Related]
16. Insulin detemir: a review of its use in the management of diabetes mellitus.
Keating GM
Drugs; 2012 Dec; 72(17):2255-87. PubMed ID: 23110609
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.
Baldwin D; Zander J; Munoz C; Raghu P; DeLange-Hudec S; Lee H; Emanuele MA; Glossop V; Smallwood K; Molitch M
Diabetes Care; 2012 Oct; 35(10):1970-4. PubMed ID: 22699288
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.
Dalal MR; Kazemi MR; Ye F
Curr Med Res Opin; 2017 Feb; 33(2):209-214. PubMed ID: 27737571
[TBL] [Abstract][Full Text] [Related]
20. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]